THE DAILY BRIEFING

A clearer view of today.

The stories that matter. The context you need.

INDEPENDENT PERSPECTIVEFree to read.
Every day.

Business

Your briefing

3 min read

AI-assisted briefingHow we put it together ↗
Tariff uncertainty rattles markets as Washington signals continuity; EU pushes back

After the Supreme Court curtailed the administration’s tariff authority, the White House and Treasury signaled they’ll pursue alternative legal avenues to maintain elevated duties, stoking fresh uncertainty across risk assets. U.S. stock futures slipped and Treasury yields climbed as investors weighed growth and inflation implications, while the EU warned it won’t accept any unilateral tariff hikes. The policy overhang has become a near-term macro driver for equities, bonds, and FX.

Source: Seeking Alpha


From AI darlings to “heavy-asset” havens: investors rotate ahead of megacap catalysts

Money is rotating out of high‑multiple AI leaders into capital‑intensive sectors seen as more resilient to policy and rate volatility. The shift comes as the market debates whether AI capex can keep compounding at recent rates and as a packed earnings slate led by Nvidia looms large. Expect positioning to stay fluid as investors balance growth duration against cash flow visibility and balance‑sheet strength.

Source: Seeking Alpha


Private credit’s liquidity test: Blue Owl gates fund as CLO risks mount

Blue Owl’s decision to gate redemptions jolted private credit, highlighting liquidity mismatches as AI‑linked bets and higher rates collide with investor outflows. Separate warnings around CLO equity funds show how leverage can magnify default risk, while hedge funds are offering exit liquidity to locked‑up investors—at steep discounts. The episode underscores the trade‑off between yield and access, with liquidity now a core due‑diligence variable for allocators.

Source: Seeking Alpha


Novo Nordisk slides as next‑gen obesity shot trails Lilly in head‑to‑head test

Novo Nordisk shares fell after a pivotal study showed its in‑development obesity drug underperformed Eli Lilly’s tirzepatide on weight loss, sharpening competitive pressures in a category central to both companies’ growth. The read‑through complicates Novo’s pipeline narrative and reinforces expectations that Lilly will retain a lead in the GLP‑1 market near term.

Source: MarketWatch


Enel pairs $1.18B buyback with $63B push into U.S./Europe renewables

Italy’s Enel unveiled a $1.18 billion share repurchase and a sweeping €58B (~$63B) investment plan to expand renewables and grids across the U.S. and Europe. The dual track signals confidence in cash generation while leaning into regulated and transition assets expected to drive multi‑year EBITDA and FFO growth.

Source: Seeking Alpha


Nvidia re‑enters PCs with AI laptop chips, intensifying on‑device inference race

Nvidia is back in the PC arena with AI‑focused laptop silicon, aiming to bring local inference and generative features to mainstream form factors. The move deepens competition across the CPU/GPU/NPU stack and widens Nvidia’s addressable market as enterprises and consumers seek hybrid AI (cloud + edge) experiences.

Source: Seeking Alpha


Crypto flows turn defensive: Bitcoin ETFs log five straight weeks of outflows as price dips

Spot Bitcoin ETFs have recorded about $3.8 billion in net outflows over five weeks, reflecting more selective institutional risk appetite. The macro risk‑off tone—exacerbated by tariff uncertainty—pushed Bitcoin below $65,000, even as regulated BTC ETFs remain the preferred institutional channel versus alt‑exposure. Flows suggest strategic positioning rather than broad capitulation, with demand concentrated in the most liquid, compliant vehicles.

Source: Seeking Alpha


You May Also Be Interested In...
Business — February 23, 2026 | Briefing24